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Abdominal aortic aneurysm (AAA) is a life-threatening disease that requires surgical repair when its size is >5.5 cm or it is growing rapidly (>1 cm/y).
1 Endovascular aneurysm repair (EVAR) and open aortic repair (OAR) are the current available options. Whereas EVAR offers superior early advantages, a recent meta-analysis concluded that survival is similar after 2 years. 2 One of the most common postoperative complications after both treatments is acute kidney injury (AKI). A real incidence of AKI after aortic surgery is difficult to evaluate as many different classifications for AKI have been proposed. Two similar staging systems have been more widely adopted: the Acute Kidney Injury Network (AKIN) 3 and Risk, Injury, Failure, Loss, End-stage (RIFLE). 4 Recently, Bang et al 5 compared the incidence of AKI according to these two classification systems and concluded that AKIN showed a better prediction of mortality after any kind of AAA repair. Moreover, Twine and Boyle 6 proposed a tailor-made classification of AKI after abdominal aortic surgery, the Aneurysm Renal Injury Score (ARISe), derived from the RIFLE criteria. These classifications are summarized in Table I . Finally, new urinary markers have been recently identified, 7, 8 but their application is not widespread in routine practice yet. In this paper, we aim to evaluate the incidence of AKI according to the ARISe classification in a large series of patients who underwent both OAR and EVAR.
METHODS
All patients who underwent OAR and EVAR in our institution from January 2009 until October 2015 were prospectively included in an Excel database. Data regarding demographics, aneurysm characteristics, operative details, and postoperative complications were noted. Inclusion criteria for aneurysm repair were AAA >5.5 cm or >4 cm rapidly growing (>1 cm/y) and iliac artery aneurysms >3 cm requiring aortobi-iliac or bifemoral open or endovascular repair. Exclusion criteria were symptomatic or ruptured AAA, need for suprarenal clamping, branched or fenestrated or chimney endografts, concomitant renal artery interventions (ie, reimplantation, angioplasty), and minor accessory renal artery ligations. In our division, EVAR is usually preferred in the following conditions: high risk for surgery (ie, severe cardiac or pulmonary disease; concomitant cancer needing surgery, chemotherapy, or radiotherapy), previous abdominal surgery, need for prolonged dual antiplatelet therapy due to recent myocardial revascularization, and patient's choice. All patients underwent routine blood tests, including determination of serum creatinine (SCr) concentration, on the day before surgery, and this parameter was considered the basal SCr value. We then considered the highest SCr value in the first 7 postoperative days or the requirement for renal replacement therapy, according to the ARISe classification, 6 and patients were divided into the five categories of this staging system. Urine output was not available in some patients, so we decided not to consider this parameter. In those patients who suffered from any stage of AKI, we reported the last SCr value available before the discharge to evaluate the reversibility of AKI. All subjects gave informed consent for the intervention. Data were collected as part of routine service evaluation and no patient-identifiable data are presented, so a local ethical committee approval was not deemed necessary for this retrospective study. The primary study end point was the incidence of AKI according to the ARISe classification. The secondary end points included the impact of AKI on postoperative outcomes and mortality, the restoration rate at the preoperative renal function after AKI, and the influence of pre-existing comorbidities on the development of AKI.
Statistical analysis. Descriptive statistics were performed using frequencies and percentages for qualitative variables, means with standard deviation, and minimummaximum values for quantitative variables. The patients' characteristics were analyzed by the c 2 test (or Fisher exact test as appropriate) for categorical variables and by the Student t-test for continuous ones, after normality distribution assessment by Shapiro-Wilk test. The main outcome was the postoperative occurrence of AKI (dependent variable); its potential association with different risk factors and complications (independent variables) was investigated by univariate and multivariate logistic regression models. The covariates included in the final multivariate model were selected through the Hosmer and Lemeshow procedure by inserting variables with a univariate P value < .25 as the main criterion, with age and gender as potential confounders. Results are expressed as odds ratios (ORs) with 95% confidence intervals (CIs), and a two-tailed P value # .05 was considered significant for all analyses.
Statistical analyses were performed with Stata/MP 13 statistical software (Stata Corp, College Station, Tex).
RESULTS
In the study period, 431 patients met the inclusion criteria. Of these, 285 (66%) underwent OAR and 146 (34%) EVAR. Demographics and preoperative data are summarized in Table II . EVAR patients were older and less frequently current smokers. Patients with history of cancer were rather treated with stent grafts; calcium channel blockers and beta-blockers were more commonly used by OAR patients, whereas angiotensin-converting enzyme inhibitors/sartans were more commonly used by EVAR patients. Interestingly, preoperative SCr concentration was almost identical in both groups. Mortality within 30 days did not significantly differ between EVAR and OAR patients (0.7% vs 1.7%; P ¼ .37). Postoperative days were significantly reduced after EVAR (4 vs 9; P < .001). AKI was much more common after OAR (26.3% vs 5.5%; P < .001), with a prevalence of stage 1 in both groups (100% vs 69% in EVAR and OAR, respectively). No patients in the OAR group required temporary or permanent renal replacement therapy (stage 4 and stage 5 of the ARISe classification). We then evaluated SCr values at discharge only in patients who developed AKI, after exclusion of those who died within 30 days (n ¼ 4, all in the OAR group). Both groups had a high proportion of restoration to preoperative SCr concentration at discharge (62.5% vs 77.5% in the EVAR and OAR groups, respectively; P ¼ .37). Table III summarizes these postoperative outcomes. We then analyzed renal outcomes in detail and divided the study population into two groups according to the development of AKI (Table IV) , and we found that preoperative SCr concentration was significantly higher in those patients who further developed AKI (1.25 vs 1.04 mg/dL; P < .001). We then performed a univariate analysis comparing patients with AKI (AKIþ, n ¼ 83) vs patients without AKI (n ¼ 348; Table V) . Those who developed AKI were more frequently current smokers as well as affected by hypertension and chronic renal disease (CRD). AKIþ patients had longer hospital stay (13.6 vs 9 days; P < .001) and higher rate of early mortality (4.8% vs 0.6%; P ¼ .01), arrhythmias (12% vs 2.9%; P < .001), and pneumonia (21.7% vs 8%; P < .001). We then tried to evaluate the impact of AKI stage by comparing stage 1 (low AKI, n ¼ 60) vs stage 2 and stage 3 (high AKI, n ¼ 23). However, there were no significant differences between these two groups, besides a longer hospital stay in the second one (18.1 vs 11.9 days; P ¼ .01). These data are summarized in the Supplementary 13; P ¼ .03) were significantly associated with an increased risk for development of AKI. Again, the multivariate analysis showed no significant differences between low and high AKI, as defined before, except for a longer hospital stay in the second group (Table VII) .
DISCUSSION
In our prospective cohort of patients with unruptured infrarenal AAA, the incidence of AKI was significantly higher after OAR than after EVAR (26.3% vs 5.5%). Interestingly, most patients who developed AKI had a restoration to their preoperative renal function at discharge in both groups (77.5% vs 62.5%, respectively). The higher incidence of AKI in the OAR group is comparable with some data from the literature, 9 even though a recent meta-analysis 2 showed no statistical differences between the two treatments. However, a comparison among different studies reporting the incidence of AKI after aortic repair is always affected by a wide heterogeneity in the use of definitions and classifications. 10 There is a lack of 11, 12 ; moreover, new markers have been evaluated in aortic surgery, such as urinary cystatin C 8, 11 and urinary liver-type fatty acid-binding protein, 7 which both appear to be promising tools, although they are still not completely validated for routine practice.
We decided to apply the classification recently proposed by Twine and Boyle (ARISe classification), 6 which is tailored to abdominal aortic repair (both endovascular and open). In accordance with that, a small rise in SCr levels (ie, 0.3 mg/dL or <50% of baseline) during the first postoperative 48 hours identifies stage 1; 50% to 99% and >100% rise within 7 days correspond to stage 2 and stage 3, respectively; last, the need for temporary or permanent renal replacement therapy refers to stage 4 and stage 5, respectively. This probably explains the relatively high rate of AKI in our cohort of OAR patients (26%), with a high prevalence of stage 1 (100% for EVAR and 69% for OAR), as it considers a very small rise in SCr concentration that can happen even in a normal postoperative recovery. For example, if we applied the RIFLE criteria as originally described by Bellomo et al, 4 not all the patients in stage 1 (according to the ARISe classification) would be identified as AKIþ, as the first stage of this classification ("risk") considers a 1.5-fold (ie, >50%) increase in SCr concentration. Having said that, the overall incidence of AKI would have been 5.3%, which is in line with data reported by Wald et al (ie, 6.7%) 13 but considerably lower if compared with the study of Tallgren et al (22%). 11 Furthermore, most patients were restored to preoperative SCr levels at discharge, which means that although it is frequent, AKI seems to be a rapidly reversible process. Specifically, this return to basal renal function was markedly evident in patients in stage 1 (85%). Consequently, we can suppose that the ARISe classification, albeit tailored to aortic surgery, probably overestimates the real clinical impact of AKI. Unfortunately, we did not report long-term renal outcomes as this was a retrospective analysis of a prospectively collected database, the main aim of which was not to establish renal outcomes after EVAR and OAR. Therefore, because we could not collect SCr values after discharge in most patients, we did not include an analysis of long-term impact of AKI. Another interesting finding of this study is that overall, higher preoperative SCr levels correspond to a higher risk of postoperative AKI. We could not perform a separate analysis for OAR and EVAR groups because of the small number of patients with AKI in the EVAR group (n ¼ 8). Parmer et al 14 evaluated AKI after both EVAR and OAR in patients with CRD and found that there were no differences between the two treatments, even if they considered 1.5 mg/dL as the threshold for CRD, whereas we use 1.2 mg/dL. Wald et al 13 also found a fivefold increased risk of AKI after OAR and EVAR in patients with pre-existing CRD. At the univariate analysis, AKI was associated with longer hospital stay, higher mortality rate, arrhythmias, and pneumonia. Furthermore, smoking, hypertension, and CRD were significant predictors of AKI. At the multivariate analysis, most of these associations remained significant. Surprisingly, age did not affect the incidence of AKI. This is in contrast with the results reported by Tallgren et al, 11 who found that AKIþ patients were significantly older than those who did not develop this complication. We observed a higher mortality rate in AKIþ patients (4.8% vs 0.6%; P ¼ .01). Four of five patients who died after OAR had AKI, whereas the only death in the EVAR group was not associated with AKI. Overall, mortality was not statistically different after the two treatments (0.7% vs 1.7% after EVAR and OAR, respectively; P ¼ .37). Postoperative AKI is generally a risk factor for mortality after different kinds of surgery. 15, 16 Regarding abdominal aortic surgery, Wald et al 13 already highlighted the higher risk of mortality (after both EVAR and OAR) in the presence of AKI (OR, 11.3%). Nevertheless, we could not include early mortality in the multivariate analysis because of the small number of cases in both groups. In agreement with Tallgren et al, 11 arrhythmias were strictly associated with AKI; this could be mainly due to a common etiology, ie, a status of hypovolemia, especially after OAR, which could be one of the causes of both pathologic processes. Conversely, there is not a clear explanation for the association between AKI and pneumonia. We defined this complication as a pulmonary consolidation on radiography with positive bronchoaspirate. Pneumonia more often occurred after OAR, 17 mostly in those patients requiring longer invasive ventilation. In some of these patients, a renal impairment could be included in a wider multiorgan failure, which can partly explain the concomitance of these two complications. Finally, we tried to estimate the impact of AKI stage on different outcomes, but no significant differences occurred between stage 1 and stages 2 and 3, except for a longer hospital stay in the latter group.
This study has several limitations. This is a retrospective analysis of a prospective cohort of patients; therefore, the main purpose of our data collection was not to assess renal outcomes after EVAR or OAR. Second, we used SCr concentration only as a parameter to define AKI, whereas in the literature, some other markers appeared to be more appropriate. 7, 8, 11, 12 Notwithstanding this, SCr is a routine blood test that would be requested in any case after aortic surgery, making it much cheaper than other markers. However, further prospective studies purposely designed for AKI evaluation should investigate and compare different markers of renal injury. Another limitation of the study is the low number of AKIþ patients in the EVAR group, which negatively affects a statistical comparison between the two types of intervention. Finally, many potentially interesting data that have been evaluated in previous works are lacking: intensive care unit stays, 18 postoperative hemodynamic parameters, 11 intraoperative and perioperative fluid management, 19, 20 contrast agent use, 5 blood losses, 5 impact of suprarenal fixation, 21 and longterm assessment of renal function. 22 A detailed report of all these parameters would have added many points of consideration to the discussion.
CONCLUSIONS
AKI is a common but transient complication, especially after open abdominal aortic surgery and in patients with pre-existing renal impairment. This complication is usually associated with other postoperative adverse outcomes and leads to higher rates of mortality. There is an urgent need of consensus to overcome the plethora of definitions and classifications of AKI, especially in abdominal aortic surgery, because the current systems may not properly reflect the actual burden of this complication. Further studies must assess which parameters should be considered reliable to evaluate the impact of AKI after any kind of abdominal aortic repair. 
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